Skip to main content
. 2022 Jan 20;14(2):241. doi: 10.3390/pharmaceutics14020241

Table 10.

EGFR-targeted PDT performed with anti-EGFR nanobodies.

Targeting Agent PS In Vitro Studies In Vivo Studies Ref.
7D12, 7D12-9G8 IRDye700DX 3T3 2.2, 14C, A431, HeLa [211]
7D12, 7D12-9G8 IRDye700DX OSC- 19-luc2-cGFP,
HeLa, SW620
OSC-19-luc2-cGFP cells in nude Balb/c female mice [212]
7D12 IRDye700DX A431, E98, SKOV-3 Clinical ascites samples [213]
7D12, 7D12-9G8 IRDye700DX A431, HeLa, HEK293T, UM-SCC-14C Patient-Derived Head and Neck Cancer Organoids [167]
7C12 RuII Polypyridyl A431, MDA-MB 435S [214]
7D12, 7D12-9G8 RDye700DX OSC-19-luc2-cGFP OSC-19-luc2-cGFP cells in female BALB/c nude mice [215]
7D12, 7D12-9G8 IRDye700DX A431, scc-U8 [216]
7D12 IRDye700DX MS1, OSC [217]
NBA IRDye700DX SCCF1, SCCF2, SCCF3, HeLa, MCF7 [218]
7D12 IRDye700DX A431 Mice bearing A431 xenografts. [219]
7D12 Benzophenothiazine A431, 4T1, MCF-7, HeLa 4T1cells in female
Balb/c mice
[220]